WebKnight Therapeutics has raised a total of $529M in funding over 8 rounds. Their latest funding was raised on Mar 23, 2024 from a Post-IPO Equity round. Knight Therapeutics is registered under the ticker TSX:GUD . Knight Therapeutics is funded by 4 investors. Armco Alberta and International Finance Corporation are the most recent investors. WebAug 5, 2024 · Founded. 2013. Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals …
2024-04-10 NYSE:BRO Press Release Brown & Brown Inc.
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange (symbol GUD), with a market capitalization of $1.02 billion as of August 2024. WebApr 12, 2024 · Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer … glyder sportswear
60 Degrees Pharmaceuticals Fast Tracked For Malaria Drug
WebMar 24, 2024 · Knight Therapeutics Inc.'s shares trade on TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company's web site at … WebKnight Therapeutics Inc stock price live 4.48, this page displays TSX GUD stock exchange data. View the GUD premarket stock price ahead of the market session or assess the after … WebKnight Therapeutics is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative … bollington surgery macclesfield